Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
In the late 1990s, the FDA expressed concerns regarding the diminishing potency of Merck & Co., Inc.’s MRK mumps vaccine as it neared its shelf life. To address these issues, Merck increased the vaccine’s initial potency; however, this adjustment …